Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.
about
Surgery in 2013 and beyondProphylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patientsScreening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patientsRole of multimodality treatment for lung cancer.The role of induction therapy in the management of resectable non-small cell lung cancer.Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.Neoadjuvant radiotherapy/chemoradiotherapy in locally advanced non-small cell lung cancer.Combined modality treatment of non-small-cell lung cancer.A new PET/CT volumetric prognostic index for non-small cell lung cancerPathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer.Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial.Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancerChemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancerCombined radio- and chemotherapy for non-small cell lung cancer: systematic review of landmark studies based on acquired citations.Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer.Therapeutic management options for stage III non-small cell lung cancer.Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: What is the role for surgery?Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer.Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.Trimodality treatment in Stage III nonsmall cell lung carcinoma: prrognostic impact of K-ras mutations after neoadjuvant therapy.The long-term outcomes of induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer.Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer.Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy.Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer.Salvage surgery for a super-responder by gefitinib therapy for advanced lung cancer.Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer.Induction chemoradiotherapy versus induction chemotherapy for potentially resectable stage IIIA (N2) non-small cell lung cancer: a systematic review and meta-analysis.A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903)
P2860
Q26863046-966EFF16-E6FA-48EC-B748-8FA877860B71Q33389562-A2F75C33-6970-4042-B65D-CFB8663EEF12Q33599261-FF2460E1-3101-407F-8AC6-024538281DB5Q33829263-8B5C98AD-C263-4B38-B636-013B439750EEQ33877447-B4B0CF14-2A05-442B-A792-A64EC2C2632EQ34666837-D2C27E70-A6E3-4B55-8910-40CF22DE9059Q34666843-7F4B2FE4-7EFB-43E0-8FA7-ABB53360C1B4Q35125456-469E1A30-12C3-4FF7-AFE3-8E88F454F331Q35627621-296353A7-FDDE-414C-B0B6-4D3A81470DBCQ35688617-07A042C8-5840-438B-A1A9-C2498CB471D7Q36525431-FB0536D1-4C0D-4C98-92CF-B061E5BE3EA6Q36609576-DB237A5F-2AE5-48D6-AABB-2A7C6E8C7E80Q36614079-967DBFFE-F5C7-43DF-89BA-875E637577BEQ36641079-69FD3912-3818-46BC-8DE7-89A32C764B46Q36694678-32E88A83-A79E-4A3D-AEE6-EFE9C641955EQ36989648-931D8942-263F-4A4B-B222-149961CB0E46Q36993644-C8E9AA51-E779-4F06-B69E-155D263F3064Q37323898-E7B20E3D-4408-4DC9-8277-EDA15CD0A05FQ37642455-F8EDBEF8-A1F5-4BB5-9AE5-4C7AD05536B2Q38818969-F616CCAF-4556-445B-A6ED-CA46C2F9BABEQ38925887-9B0A26E6-9FB6-477F-963B-793F3962A776Q40636438-E83B9B64-6E36-45D3-AA70-622674663B5DQ40648657-4D2C9078-F751-4C89-975A-FA93321A296DQ43055346-DF38DA37-F903-4814-B32F-0B822FC1F3AFQ43773748-899F57B1-B632-4538-9783-5B9B92023FC5Q48409755-2D1FE35E-5F57-4B9D-882D-E7FF19778F57Q49256406-9110F45D-F58E-4017-A69F-06ECED98A8C8Q51332718-C264945E-844E-490A-88D1-0653300F8363Q53077267-3E57837B-2592-4971-8343-058BA2A1C7B5Q53826389-E94E2EDF-11CB-4F63-B837-34D318F30B5CQ55092203-CC01B794-C8DF-4CDD-9540-C6D4416D7874Q58454636-93300280-1737-4678-B1A5-0C626D26A7F1
P2860
Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Potential impact on survival o ...... IA non-small-cell lung cancer.
@ast
Potential impact on survival o ...... IA non-small-cell lung cancer.
@en
type
label
Potential impact on survival o ...... IA non-small-cell lung cancer.
@ast
Potential impact on survival o ...... IA non-small-cell lung cancer.
@en
prefLabel
Potential impact on survival o ...... IA non-small-cell lung cancer.
@ast
Potential impact on survival o ...... IA non-small-cell lung cancer.
@en
P2093
P1476
Potential impact on survival o ...... IA non-small-cell lung cancer.
@en
P2093
D Mathisen
M Grossbard
P304
P356
10.1200/JCO.1997.15.2.712
P407
P577
1997-02-01T00:00:00Z